tiprankstipranks
Ventyx Biosciences (VTYX)
NASDAQ:VTYX
US Market

Ventyx Biosciences (VTYX) Financial Statements

243 Followers

Ventyx Biosciences Financial Overview

Ventyx Biosciences's market cap is currently ―. The company's EPS TTM is $-3.242; its P/E ratio is -0.79; Ventyx Biosciences is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $-0.58. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -50.35M$ -54.03M$ -53.24M$ -38.93M$ -39.88M
EBITDA$ -49.94M$ -53.76M$ -53.10M$ -38.80M$ -39.76M
Net Income Common Stockholders$ -46.75M$ -54.03M$ -53.25M$ -38.93M$ -35.21M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 252.22M$ 300.82M$ 332.25M$ 376.92M$ 317.94M
Total Assets$ 277.69M$ 321.70M$ 348.76M$ 388.58M$ 371.40M
Total Debt$ 12.51M$ 12.33M$ 1.36M$ 1.46M$ 1.56M
Net Debt$ -239.71M$ -288.49M$ -330.89M$ -375.45M$ -316.38M
Total Liabilities$ 33.77M$ 38.06M$ 20.96M$ 17.55M$ 17.50M
Stockholders Equity$ 243.92M$ 283.64M$ 327.81M$ 371.62M$ 353.89M
Cash Flow-
Free Cash Flow$ -51.87M$ -34.71M$ -49.48M$ -30.98M$ -47.38M
Operating Cash Flow$ -51.66M$ -34.66M$ -49.28M$ -30.92M$ -47.26M
Investing Cash Flow$ 46.13M$ 38.89M$ 34.82M$ -18.89M$ -140.84M
Financing Cash Flow$ 585.00K$ 1.63M$ 2.47M$ 48.65M$ -10.36M
Currency in USD

Ventyx Biosciences Earnings and Revenue History

Ventyx Biosciences Debt to Assets

Ventyx Biosciences Cash Flow

Ventyx Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis